DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
3 Red Flags in Telemedicine Partnerships
In this video, Darshan discusses recent enforcement trends show three weak spots to watch:
- Encounter Quality – If prescribers are just checking boxes without real patient relationships, it’s not care—it’s exposure. Demand documented standards, ID proofing, intake, decision support, and supervision. Don’t take claims at face value—audit them.
- Cash Flow Logic – Murky subscription fees, misuse of facility fees, or volume-driven compensation are red flags. Require transparent fee schedules, fair market value memos, and ongoing monitoring.
- Referral Data Architecture – Patient steering crosses compliance lines. Keep education, navigation, and clinical decisions separate from marketing. Document clear pathways.
Due Diligence Toolkit: credentialing, exclusion checks, state coverage policies, encounter blueprints, billing guardrails, HIPAA/data-sharing mapping, anti-kickback controls, escalation and audit playbooks.
Takeaway Question: Where is your telemedicine workflow weakest—encounter quality, cash flow, or referral steering?
